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Abstract
Background: The peritoneal injection of monosodium glutamate (MSG) can induce kidney injury in adult rats but the
effects of long-term oral intake have not been determined.
Methods: We investigated the kidney histology and function in adult male Wistar rats that were fed ad libitum with a
standard rat chow pellet and water with or without the addition of 2 mg/g body weight MSG/day in drinking water
(n=10 per group). Both MSG-treated and control animals were sacrificed after 9 months when renal function
parameters, blood and urine electrolytes, and tissue histopathology were determined.
Results: MSG-treated rats were more prone to kidney stone formation, as represented by the alkaline urine and
significantly higher activity product of calcium phosphate. Accordingly, 3/10 MSG-treated rats developed kidney
stones over 9 months versus none of the control animals. Further, 2/10 MSG-treated rats but none (0/10) of the
controls manifested hydronephrosis. MSG-treated rats had significantly higher levels of serum creatinine and
potassium including urine output volume, urinary excretion sodium and citrate compared to controls. In contrast,
MSG-treated rats had significantly lower ammonium and magnesium urinary excretion.
Conclusion: Oral MSG consumption appears to cause alkaline urine and may increase the risks of kidney stones
with hydronephrosis in rats. Similar effects in humans must be verified by dedicated studies.
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Introduction
Monosodium glutamate (MSG) is used as a flavor enhancer
in food preparation to increase its palatability [1,2] and the
MSG consumption is growing worldwide with average daily
intake estimated as 3-4 g/day [3-5]. The Food and Drug
Administration (FDA) has determined MSG as safe for the
general population and accordingly stated that an Acceptable
Daily Intake (ADI) is not specified [1,6]. However, recent
studies support the hypothesis that MSG consumption may be
associated with overweight, the metabolic syndrome, or arterial
hypertension [3-5,7] albeit these conclusions remain debated
[8,9]. No data are available on the effects of MSG on the
urinary apparatus and kidney function in humans. Of note,
chronic oral MSG intake in rats leads to changes in antioxidant
systems and renal markers including lipid peroxidation
byproducts [10], in agreement with what observed in rats
injected with MSG [11]. Moreover, dietary MSG increases the
urinary pH in rats [12] and alkaline urine may influence the
kidney capacity to secrete or reabsorb metabolites that
contribute to stone formation, as in the case of calcium
phosphate products [13]. Based on these observations we
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hypothesized that chronic oral MSG consumption may increase
the risk of renal stone formation and renal function impairment
and the aim of the present study is to investigate the




MSG used in this study was a commercially available 99%-
pure food-grade package, while all other chemicals and
solvents were of analytical grade. Adult male Wistar rats
(150-200g) were obtained from the National Laboratory Animal
Center (Salaya, Mahidol University, Bangkok, Thailand) and
housed under controlled laboratory conditions of temperature
(25 ± 2 °C), humidity (60%) and 12 h light/12 h dark cycle. All
experiments were done under the guideline of the Northeast
Laboratory Animal Center (NELAC), Khon Kaen University,
Thailand, and approved by the Animal Ethics Committee of
Khon Kaen University, Thailand.
Experimental design
A group of 6-week old rats (n=20) received a standard rat
chow pellet (Perfect Companion Group, Bangkok, Thailand)
and water ad libitum. In the treated group (n=10), MSG was
added to drinking water to achieve a daily dose of 2 mg/g body
weight as estimated by daily water intake measurements.
Mean MSG consumption was calculated from the amount of
MSG water consumed daily, and expressed in mg per gram of
body weight. The MSG concentration in drinking water based
on the weekly water intake and previous body weight ranged
between 0.6%-2.0% during the 9 months of the study. Food
intake and body weight were recorded every one and two
weeks, respectively. Animals of both groups were sacrificed 9
months later by intraperitoneal Nembutal injection (euthanizing
dose) after 12-hour fasting. Urine samples were collected one
week before sacrifice. The animals were housed in individual
stainless steel metabolic cages designed for the separate
collection of urine and a 24-hour urine sample was collected
from each animal. Urine volumes were recorded and samples
were kept at −70°C until analyzed. Blood samples were
collected on the day of sacrifice by abdominal venous puncture
and serum and plasma were separated by centrifugation at
1500xg, 4°C for 10 minutes and stored at −70°C until analyzed.
Kidneys were washed with normal saline, dissected, and fixed
in 4% paraformaldehyde solution for histopathological analysis.
Histology
Routinely processed paraffin-embedded tissue blocks were
sliced at 4 µm thickness. Sections were stained with
Haematoxylin & Eosin (H&E) and observed under a light
microscope (Primo Star, Zeiss). To determine the percentage
of fibrosis, kidney sections were stained with Masson’s
Trichrome, scanned by ScanScope slide scanner (Aperio) and
interpreted using Aperio ImageScope Version 11.1.2.752.
Glomeruli were excluded and the remaining areas were
analyzed by positive pixel count protocol; blue areas of Masson
staining were counted as negative pixel. The fibrotic results
were calculated by negative pixel x100 divided by total pixels.
Analysis of renal sections for stone crystals was done under a
polarized light microscope (Olympus BX 51).
Serum and urine biochemistries
Serum creatinine and blood urea nitrogen (BUN)
concentrations were determined by Jaffe [14] and diacetyl
monoxime [15] methods, respectively. Inorganic phosphate
concentration was determined as described elsewhere [16].
Urinary analyses included the measurements of ammonium by
Chaney et al. 1962 [17], calcium and magnesium by atomic
absorption [18], and protein by Lowry’s method [19]. Serum
and urine electrolytes were analyzed by auto analyzer
(Automate Cobas C6000). Citrate in urine was estimated by a
new citrate lyase method [20]. Based on the urinary excretion
of calcium, citrate, phosphate, urine pH and the urine volume,
we then calculated the ion-activity products of calcium
phosphate [AP(CaP)] [21]. The index estimates the risk of in





Continuous variables are expressed as mean ± standard
deviation and differences between groups were compared for
statistical significance by Student t-test. All comparisons were
two-tailed and P values < 0.05 were considered statistically
significant.
Results
Growth, food, water, MSG, and Na intake
Animals allocated to the MSG or control groups had similar
daily food intake, body weight and kidney weight at the end of
the study (Figure 1a, 1c and Table 1). On the other hand,
MSG-treated rats had a significantly higher daily water intake
compared to controls throughout the study (Figure 1b). Based
on the similar daily food intake (22g/day) and the provided food
containing 0.2 g% Na, all rats received 0.044 g/day Na from
regular chow. Further, in MSG-treated rats the mean ± SD daily
MSG intake was 2.10 ± 0.32 mg/g body weight throughout the
study corresponding to 0.29 ± 0.04 mg/g bw/day (0.19 g/day)
Na from MSG supplementation.
Kidney pathology
The kidney gross anatomical examination revealed the
presence of lithiasis in 3/10 MSG-treated rats and 0/10
controls. Kidney stones were minute, white in color with smooth
surface, numerous in numbers and localized in the calyx and
pelvis area (Figure 2a). In 2 of the 3 cases the lithiasic kidneys
manifested flattened and atrophic renal papillae out of
proportion to the cortex, which is the characteristic feature of
hydronephrosis (Figure 2b). Intra-luminal white crystals were
also observed in the kidney tissue of 2/10 treatment animals
but 0/10 controls under polarized microscope supporting pre-
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Table 1. Body weight, water, food intake, and kidney weight
in control and MSG-treated rats at 9 months.
 Control (n=10) MSG (n=10)
Baseline (6 weeks) body weight (g) 204.3 ± 12.1 204.7 ± 12.5
Final body weight (g) 680 ± 118 665 ± 75
Daily water intake (ml) 57 ± 10 84 ± 16*
Daily food intake (g) 22 ± 3.7 22 ± 0.5
Kidney weight (g) 1.42 ± 0.17 1.50 ± 0.24
Variables are expressed as mean ± standard deviation. *p < 0.05
doi: 10.1371/journal.pone.0075546.t001
lithiasis (Figure 2c). It should be noted that one of the animals
with intra-luminal crystal is not the same animal with renal
stone. Further histological examination revealed the hyaline
casts including the flattening of the tubular epithelium in both
groups at similar levels (Figure 2d, 2e). By histological
quantification, the kidneys of MSG-fed rats had significantly
increased interstitial fibrosis (17.6 ± 6.3%) compared to those
of controls (8.7 ± 6.2%) (Figure 3).
Blood and urine biochemistries
Urine analyses demonstrated that MSG-treated rats had
significantly higher urine pH and urine output compared to
controls (Table 2). The daily urinary excretion of sodium and
Figure 1.  Mean food intake (a), water intake (b), and growth curve (c) in 10 rats from the MSG-treated and control groups
at different time-points over 9 months.  
doi: 10.1371/journal.pone.0075546.g001
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citrate were also significantly higher in the MSG group while
the amount of urinary ammonium and magnesium were
significantly lower compared to the control group. Most notably,
MSG treated-group had significantly higher AP(CaP) value
(135.77 ± 124.46) compared to controls (6.76 ± 6.01) (Figure
4). There were no significant differences in the urine excretion
of potassium, chloride, calcium and phosphate between
groups. At the end of the study period, serum creatinine was
significantly higher in the MSG group compared to controls
(Table 3). Among blood electrolytes, serum potassium levels
were significantly higher in MSG-treated rats than in controls,
but all other electrolytes (Na+, Cl-, HCO3-, Ca2+, PO42-, Mg2+)
were comparable between both groups.
Stone composition
Regarding a small quantity of collected stones, only the
calcium level can be determined. Using the atomic absorption
method, the level of calcium was approximately 1 ppm.
Discussion
MSG is gaining a central role as a flavor enhancer in
modern-day cuisine, particularly of Asian Pacific countries. At
present, an acceptable daily intake for MSG in humans
remains undetermined and intakes of 0-120 mg/kg body weight
were suggested in 1974 by the WHO. Accordingly, the
Scientific Committee for Food (SCF) at the European
Commission mentioned in 1991 that MSG is associated with an
“ADI not specified” and this remains the current indication in
the European Union. However, a dose of 150 mg/kg body
weight has been mentioned as safe [6] and has been tested in
healthy volunteers [22] while in our previous study some of the
subjects also consumed MSG in the same range (0.4-14 g/day)
[5]. Based on dose translation between rodents and humans
[23], the MSG dose used in the present study is 22.7 g/day for
a 70 kg man which is approximately 2-3 times higher than the
safe dose that has been used in healthy volunteers [22] and
Figure 2.  Macroscopic appearance of one representative case of urolithiasis in the MSG group (a).  Virtual scanning of H&E
kidney sections of MSG treated animal with moderate hydronephrosis (5x) in 9 months (b). Crystal in the kidney tissue under dark
field illumination with polarized microscope (Olympus BX51) in 9 months MSG-treated animal (200X) (c). H&E staining revealed the
hyaline casts including the flattening of the tubular epithelium in both control (d) and MSG-treated tissues (e) (100x).
doi: 10.1371/journal.pone.0075546.g002
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5-6 times higher than the current reported consumption in
Asian Countries [3-5].
The association between dietary factors, including MSG, and
the risk of kidney disease has been proposed in numerous
studies without reaching solid conclusions. In previous
experiments, MSG supplementation either by injection [11] or
oral intake [10,24] induced kidney damage but we report herein
for the first time that the chronic consumption of dietary MSG
causes obstructive nephropathy from urolithiasis in adult rats
possibly via urine alkalinization which predispose to CaP
precipitation.
It should be noted that all MSG-treated rats had alkaline
urine. We suspected that MSG-treated animals may generate
higher catabolic products of glutamate in kidney cells and its
carbon skeleton is converted into carbon dioxide (CO2) and
then to bicarbonate anion [25-27]. The generated bicarbonate
is then absorbed back to blood circulation and ultimately to
kidney for excretion of the extra-alkali, exhibiting alkaline urine
[28,29]. Despite the unknown mechanism by which oral MSG
increases urinary pH, urine analysis of MSG-treated rats such
as significantly higher excretion of citrate but lower excretion of
ammonium resemble what is observed in alkali-loaded animals
[30]. This should be a renal compensation mechanism to
neutralize alkali by lowering the excretion of ammonium ion
(NH4+), while elevating the excretion of organic anion such as
citrate during the alkali load [30-32]. The significant decrease in
magnesium excretion found in MSG-treated rats may also be
secondary to alkaline urine or alkali loading, consistent with a
Figure 3.  Renal interstitial fibrosis in 9 months MSG-treated animals (100x).  
doi: 10.1371/journal.pone.0075546.g003
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previous study that a decrease of Mg excretion was found in
bicarbonate treated animals [33].
Alkaline urine has also been reported in rats receiving 6%
dietary MSG for 3 months [12] and a similar observation was
found in the present study with a 3-fold lower dose. It has been
noted that urine pH exceeding 6.8 enhances the precipitation of
urine constituents like CaP by 3-fold [34]. In agreement with
our finding that MSG-treated rats had significantly higher value
of AP(CaP) compared to controls. An increase of AP value
indicated the risk of calcium-phosphate stone formation [21].
Based on the microscopic examination revealing intra-tubular
crystals and the detectable calcium level in stone samples
including alkaline urine, we are convinced that the stone found
in MGS-treated rats is composed of calcium phosphate.
Urinary tract obstruction secondary to stones caused
hydronephrosis in a subgroup of MSG-treated rats and the
impaired renal function may result from the tubular damage
and obstruction, thus causing renal dysfunction represented by
the increase in serum creatinine and possibly potassium in
MSG-treated rats. A similar degree of serum creatinine level
increase had been previously reported following the oral
exposure to a significantly higher amount of MSG [10].
Hydronephrosis was observed only in MSG-treated rats but
not in control animals. Such moderate hydronephrosis
resembles the effects of partial ureteral obstruction in rats [35]
and obstructive nephropathy causes major changes in the
tubulo-interstitial compartment of the kidney and renal
interstitial fibrosis is a common long-term consequence [36].
We are convinced that this phenomenon may cause the kidney
interstitial fibrosis observed in MSG-treated rats while oxidative
stress secondary to MSG may also contribute [10] as reactive
oxygen species induce the transmodulation of fibroblasts to
myofibroblasts [37]. Tubular interstitial fibrosis is the strongest
morphological predictor of clinical outcome in kidney disease,
and is tightly associated to the progression of renal diseases
[38].
We are aware of specific issues that may strengthen our
findings or limit the impact of the data. First and foremost, both
groups were given standard rodent diet and water ad libitum
throughout the 9-months of observation, with the addition of
MSG in drinking water as the sole difference. As expected, the
MSG dose used in this study did not affect the growth and
development of rats nor the daily food intake, as reported by
Collison and Colleagues [39,40]. The total amount of MSG
(0.6-2%) added in drinking water in this study is within the
0.2-8% dose range used in previous studies [10,41]. Second,
the lithogenic effect of MSG may have been attenuated by the
increased water consumption by MSG-treated rats, as well as
the increased urinary citrate levels which counteract stone
formation. Third, it should be noted that Wistar rats are
susceptible to age-related nephropathy [42] and it has been
reported that by 6 months of age, Wistar rats show minimal
changes with scattered sclerotic glomeruli, a few foci of tubules
dilated with eosinophilic (hyaline) casts and small mononuclear
cell infiltrates in the interstitial tissue [43]. We also found
features such as hyaline casts, and flattening of tubular
epithelium in both control and MSG-treated groups. As a result,
we cannot rule out the possibility that the strain susceptibility
and aging may have concurred to the onset of kidney disease.
Nevertheless, obstructive nephropathy had not been reported
before in older rats.
Fourth, the standard rat chow used in this study had 24%
protein content which may have some causal link with
observed kidney pathology. It has been reported that protein-
rich diets may cause a marked increase in water consumption,
urine production and proteinuria [42]. We hypothesize that the
increase in water consumption by MSG-treated rats may be
secondary to MSG itself and not the high protein consumption
since control and MSG-treated rats received the same amount
of dietary protein. Further, the increase in water consumption of
rats with a high protein diet was observed after 15 months [42]
while the increased urine output found in both studies is likely
proportional to water intake. As control rats had no obstructive
nephropathy despite receiving similar amounts of protein, it is
less likely that the obstructive nephropathy found in MSG-
treated rats is related to the high protein diet.
Finally, features of MSG-treated rats resemble that of
animals with a sodium-rich diet as increased water intake, high
urinary sodium level, and fibrosis were reported also in
Sprague Dawley rats receiving 8% NaCl diet for 3 weeks [44].
However, we are convinced that the changes observed in the
present study do not recapitulate sodium enrichment. Indeed,
Table 2. Urine biochemistry in control and MSG-treated rats at 9 months of study.
 Control (n=10) MSG (n=10) P value  
Urine Volume (ml/day) 26.9 ± 7.2 51.5 ± 23.6 < 0.01  
Urine pH 6.6 ± 0.6 8.7 ± 0.4 < 0.001  
Sodium (mEq/day) 1.0 ± 0.5 6.1 ± 2.9 < 0.001  
Potassium (mEq/day) 4.1 ± 1.2 4.8 ± 1.5 NS  
Chloride (mEq/day) 1.3 ± 0.6 1.8 ± 0.7 NS  
Calcium (mg/day) 3.9 ± 1.2 4.1 ± 1.2 NS  
Phosphate (mg/day) 36 ± 15 39 ± 5 NS  
Citrate (mmol/day) 0.43 ± 13 0.77 ± 0.16 < 0.001  
Ammonium (mmol/day) 1.41 ± 0.39 0.38 ± 0.19 < 0.001  
Magnesium (mg/day) 4.1 ± 0.9 2.0 ± 1.1 < 0.001  
Variables are expressed as mean ± standard deviation. NS, not significant.
doi: 10.1371/journal.pone.0075546.t002
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sodium-loading animals manifested elevated calcium excretion
that was not observed in MSG-treated rats and 8-week sodium
intake was not associated with changes in serum creatinine
and electrolyte (Na, K, Cl, Ca, Mg, P) levels [45], different from
MSG-treated rats. Furthermore, the significant higher of urinary
Ca, Cl, and Mg excretion found in sodium-loading rats is also
opposite of what was observed in MSG-treated rats [45]. Most
importantly, the total sodium intake in MSG-treated rats (0.32
g/kg) did not exceed the daily requirement (0.5 g/kg) [46] and
the 24-hour sodium urinary excretion was within the normal
range.
Conclusions
Our data support the hypothesis that high doses of oral MSG
cause urinary alkalinization and CaP saturation in rats thus
possibly predisposing to kidney stone formation with
subsequent hydronephrosis and interstitial fibrosis. While we
are aware that the dosages employed in this study are in the
higher range, albeit not infrequent in Asian real-life, we
encourage human studies to observe whether this association
is confirmed.
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